Metraipolis › archive › dc_eb54eca3f35e
Phase I dose-ascending, safety, and pharmacokinetics study of APC148, a novel metallo-β-lactamase inhibitor, in healthy volunteers — Europe PMC PMID:42307233
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42307233
- DOI
- 10.1128/aac.00426-26
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T08:52:00.201Z
- SHA-256 of the archived text
74c62aa90c04515a6c5da6042446bc058d7c2cb91cbaa7ab133f7b85fcfb8188- Stable URL of this page
https://metraipolis.com/documento/dc_eb54eca3f35e
How to cite
Phase I dose-ascending, safety, and pharmacokinetics study of APC148, a novel metallo-β-lactamase inhibitor, in healthy volunteers — Europe PMC PMID:42307233 — Europe PMC (en), https://europepmc.org/article/MED/42307233 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eb54eca3f35e (Metraipolis archive dc_eb54eca3f35e, sha256 74c62aa90c04515a6c5da6042446bc058d7c2cb91cbaa7ab133f7b85fcfb8188)
BibTeX
@misc{dceb54eca3f35e,
title = {Phase I dose-ascending, safety, and pharmacokinetics study of APC148, a novel metallo-β-lactamase inhibitor, in healthy volunteers — Europe PMC PMID:42307233},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42307233},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eb54eca3f35e; sha256 74c62aa90c04515a6c5da6042446bc058d7c2cb91cbaa7ab133f7b85fcfb8188},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42307233. Agents can read the archived copy with the MCP tool read_document.